Your browser doesn't support javascript.
loading
Validation of a diagnostic flowchart for tuberculous pleurisy in pleural fluid with high levels of adenosine deaminase.
Shimoda, Masafumi; Tanaka, Yoshiaki; Ohe, Takashi; Ishiguro, Takashi; Suzuki, Atsushi; Kurahara, Yu; Shimatani, Yasuaki; Matsushima, Hidekazu; Kusano, Kenji; Ohta, Hiroki; Yanagisawa, Satoru; Kozu, Yuki; Yui, Takaya; Igarashi, Shunya; Kimizuka, Yoshifumi; Honda, Kojiro; Otani, Sakiko; Chiba, Shigeki; Xu, Dongjie; Mitsui, Miho; Waseda, Yuko; Ishii, Haruyuki.
Afiliação
  • Shimoda M; Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, 204-8522, Japan; Department of Respiratory Medicine, Kyorin University Faculty of Medicine, Mitaka City, Tokyo, 181-8611, Japan. Electronic address: shimodam@fukujuji.org.
  • Tanaka Y; Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, 204-8522, Japan.
  • Ohe T; Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose City, Tokyo, 204-8522, Japan.
  • Ishiguro T; Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Kumagaya City, Saitama, 360-0197, Japan.
  • Suzuki A; Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Kumagaya City, Saitama, 360-0197, Japan.
  • Kurahara Y; Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Sakai City, Osaka, 591-8025, Japan.
  • Shimatani Y; Department of Clinical Laboratory, NHO Kinki Chuo Chest Medical Center, Sakai City, Osaka, 591-8025, Japan.
  • Matsushima H; Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama city, Saitama, 330-0081, Japan.
  • Kusano K; Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama city, Saitama, 330-0081, Japan.
  • Ohta H; Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama city, Saitama, 330-0081, Japan.
  • Yanagisawa S; Division of Respiratory medicine, Saku Central Hospital Advanced Care Center, Saku City, Nagano, 385-0051, Japan.
  • Kozu Y; Division of Respiratory medicine, Saku Central Hospital Advanced Care Center, Saku City, Nagano, 385-0051, Japan.
  • Yui T; Division of Respiratory medicine, Saku Central Hospital Advanced Care Center, Saku City, Nagano, 385-0051, Japan.
  • Igarashi S; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa City, Saitama, 359-0042, Japan.
  • Kimizuka Y; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa City, Saitama, 359-0042, Japan.
  • Honda K; Department of Respiratory medicine, Tokyo Metropolitan Tama Nanbu Regional Hospital, Tama City, Tokyo, 206-0036, Japan.
  • Otani S; Department of Respiratory medicine, Tokyo Metropolitan Tama Nanbu Regional Hospital, Tama City, Tokyo, 206-0036, Japan.
  • Chiba S; Department of Respiratory Medicine, Japanese Red Cross Sendai Hospital, Sendai City, Miyagi, 982-0801, Japan.
  • Xu D; Department of Respiratory Medicine, Japanese Red Cross Sendai Hospital, Sendai City, Miyagi, 982-0801, Japan.
  • Mitsui M; Department of Respiratory medicine, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Fukui, 910-1193, Japan.
  • Waseda Y; Department of Respiratory medicine, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Fukui, 910-1193, Japan.
  • Ishii H; Department of Respiratory Medicine, Kyorin University Faculty of Medicine, Mitaka City, Tokyo, 181-8611, Japan.
Respir Investig ; 62(6): 963-969, 2024 Aug 25.
Article em En | MEDLINE | ID: mdl-39186880
ABSTRACT

INTRODUCTION:

Adenosine deaminase (ADA) in pleural fluid is a useful marker for diagnosing tuberculous pleurisy. However, recent studies have reported a lower specificity of pleural fluid ADA levels. We previously developed a diagnostic flowchart for patients with pleural fluid ADA ≥40 U/L, incorporating variables such as pleural fluid lactate dehydrogenase <825 U/L, predominant pleural fluid neutrophils or cell degeneration, and a pleural fluid ADA/total protein ratio <14. This flowchart was effective in distinguishing between tuberculous pleurisy and other diseases. Here, we conducted a validation analysis of this flowchart. MATERIALS AND

METHODS:

We retrospectively collected data from 458 patients with pleural fluid ADA concentrations ≥40 U/L across eight institutions from January 2019 to December 2023. The diagnostic accuracy rate, sensitivity, and specificity of the diagnostic flowchart were analysed and compared to those in the original study.

RESULTS:

Eighty-seven patients were diagnosed with tuberculous pleurisy, and 371 patients were diagnosed with other diseases. The diagnostic accuracy, sensitivity, and specificity for diagnosing tuberculous pleurisy were 77.7%, 86.2%, and 75.7%, respectively. Compared with that in the original study, the rate of tuberculous pleurisy was lower (19.0% vs. 44.5%, p < 0.001), but the diagnostic accuracy rates were not significantly different (p = 0.253). On the basis of the findings from this validation study, we have revised the flowchart to enhance its utility.

CONCLUSION:

The diagnostic flowchart exhibited high diagnostic accuracy in this validation study, comparable to that in the original study. This validation confirms the effectiveness of the flowchart, even in settings with a low incidence of tuberculosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Respir Investig Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Respir Investig Ano de publicação: 2024 Tipo de documento: Article